BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 114 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $1,337,000 | -8.5% | 23,476 | -14.0% | 0.04% | +5.7% |
Q3 2019 | $1,461,000 | -21.0% | 27,299 | -11.8% | 0.04% | -12.5% |
Q2 2019 | $1,849,000 | +112.8% | 30,961 | +122.0% | 0.04% | +110.5% |
Q1 2019 | $869,000 | -57.5% | 13,945 | -58.6% | 0.02% | -64.2% |
Q4 2018 | $2,043,000 | +0.3% | 33,707 | -3.2% | 0.05% | +26.2% |
Q3 2018 | $2,036,000 | +17.3% | 34,827 | -11.3% | 0.04% | +27.3% |
Q2 2018 | $1,736,000 | -7.8% | 39,269 | -7.5% | 0.03% | -17.5% |
Q1 2018 | $1,883,000 | +14.5% | 42,462 | +11.6% | 0.04% | +14.3% |
Q4 2017 | $1,645,000 | -20.0% | 38,033 | -13.5% | 0.04% | -12.5% |
Q3 2017 | $2,055,000 | -25.0% | 43,974 | -20.5% | 0.04% | -27.3% |
Q2 2017 | $2,740,000 | +18.3% | 55,338 | +30.9% | 0.06% | -1.8% |
Q1 2017 | $2,317,000 | -9.8% | 42,284 | -8.3% | 0.06% | -38.5% |
Q4 2016 | $2,569,000 | -0.7% | 46,115 | -18.6% | 0.09% | +13.8% |
Q3 2016 | $2,588,000 | -11.7% | 56,673 | -22.7% | 0.08% | -17.5% |
Q2 2016 | $2,930,000 | -1.5% | 73,361 | -14.1% | 0.10% | +14.1% |
Q1 2016 | $2,974,000 | +16.0% | 85,406 | +43.6% | 0.08% | +41.7% |
Q4 2015 | $2,563,000 | – | 59,481 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|